MIM
ERAS icon

MetLife Investment Management’s Erasca ERAS Stock Holding History

MetLife Investment Management’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.68M Buy
103,644
+23,276
+29% +$275K 0.01% 1149
2025
Q4 		$299K Sell
80,368
-9,682
-11% -$27.2K ﹤0.01% 2069
2025
Q3 		$196K Sell
90,050
-22,298
-20% -$35.5K ﹤0.01% 2326
2025
Q2 		$143K Buy
112,348
+18,754
+20% +$25.1K ﹤0.01% 2362
2025
Q1 		$128K Sell
93,594
-19,131
-17% -$32.8K ﹤0.01% 2411
2024
Q4 		$283K Buy
112,725
+9,039
+9% +$24.8K ﹤0.01% 2115
2024
Q3 		$283K Buy
103,686
+35,355
+52% +$99.6K ﹤0.01% 2099
2024
Q2 		$161K Buy
68,331
+26,291
+63% +$56.7K ﹤0.01% 2373
2024
Q1 		$86.6K Buy
42,040
+4,763
+13% +$9.52K ﹤0.01% 2599
2023
Q4 		$79.4K Hold
37,277
– – ﹤0.01% 2694
2023
Q3 		$73.4K Hold
37,277
– – ﹤0.01% 2740
2023
Q2 		$103K Hold
37,277
– – ﹤0.01% 2664
2023
Q1 		$112K Hold
37,277
– – ﹤0.01% 2499
2022
Q4 		$161K Hold
37,277
– – ﹤0.01% 2380
2022
Q3 		$291K Hold
37,277
– – ﹤0.01% 2045
2022
Q2 		$208K Hold
37,277
– – ﹤0.01% 2302
2022
Q1 		$321K Buy
37,277
+28,917
+346% +$335K ﹤0.01% 2062
2021
Q4 		$130K Hold
8,360
– – ﹤0.01% 2306
2021
Q3 		$177K Buy
+8,360
New +$172K ﹤0.01% 2169

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

MetLife Investment Management's ERAS Position: Q1 2026 in Review

MetLife Investment Management increased its Erasca (ERAS) stake by 29% in Q1 2026, buying an estimated $275K and bringing the position to 103,644 shares worth $1.68M. The position accounts for 0.01% of the portfolio, ranked #1149.

MetLife Investment Management first reported a position in ERAS in Q3 2021 and has held it in 19 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • MetLife Investment Management held 103,644 shares of Erasca worth $1.68M as of Q1 2026.
  • MetLife Investment Management bought 23,276 Erasca shares in Q1 2026, an estimated $275K.
  • Erasca made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1149 holding.
  • MetLife Investment Management first reported a position in Erasca in Q3 2021 and has held it in 19 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.